Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News

October
12

EANO 2016

Read Full Story

October
22

18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story

November
16

2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Cleveland Clinic

Cleveland Clinic
9500 Euclid Ave.
Cleveland, OH  44195
USA

Gene H. Barnett, M.D.
Robert Weil. M.D.

Contact:
Jackie Garcia, Fellowship Coordinator
garciaj2@ccf.org
216-445-7641
 

Research Categories:

    -Genetic investigation of malignant and benign gliomas
    -Etiology and pathogenesis of metastatic brain tumors
    -Stem cells and stem tumor cells
    -Benign brain tumors including meningioma, pituitary adenoma, and neurocutaneous disorders
    -Clinical research:clinical trials, clinical outcomes, and epidemiology
    -Translational research including brain tumor modeling and convection-enhanced delivery
    -Immunotherapy
    -Clinical outcomes of stereotactic radiosurgery and stereotactic spinal radiosurgery

Research Interest/Projects:

    -Dr. Gene Barnett: Genetic investigation of brain tumors; clinical trials of novel therapeutic interventions; modeling of brain
     tumor growth; computer-aided brain navigation and interrogation; immunotherapy
    -Dr. Lilyana Angelov:  Clinical trials; CNS lymphoma; cranial and spinal radiosurgery outcomes
    -Dr. Samuel Chao:  Clinical trials, radiosurgery outcomes; pathogenesis of radiation necrosis
    -Dr. Bruce Cohen:  pediatric brain tumors and neurocutaneous disorders; mitochondrial diseases
    -Dr. James Finke:  immunotherapy of brain tumors
    -Dr. Candece Gladson: basic biology of brain tumorigenesis, invasion and migration; angiogenesis
    -Dr. Jaharal Haque:  Role of STAT and interleukin signaling in gliomagenesis and invasion; role of glioma tumor stem
     cells in tumor formation and regulation by JAK-STAT and MYC pathways
    -Dr. David Peereboom:  clinical trials, including Phase I-Phase III trials
    -Dr. Greg Plautz:  immunotherapy of glioma tumor stem cells
    -Dr. Richard Prayson:  Clinical and translational pathology of primary and metastatic brain tumors, benign and malignant
    -Dr. Jeremy Rich:  Basic and applied science glioblastoma tumor stem cells, including treatment sensitivity and
     radiobiological effects
    -Dr. Glen Stevens:  Neuro-oncology clincal research and outcomes
    -Dr. John Suh: Clinical trials, radiosurgery outcomes
    -Dr. Tanya Tekautz: Pediatric tumor clinical tirals and tumor outcomes; analysis of BRAF alterations and tumor treatment
     outcomes
    -Dr. Michael Vogelbaum:  Clinical trials; translational research, including translational research including brain tumor
     modeling and convection-enhanced delivery
    -Robert Weil:  genomic and proteomic analysis of primary and metastatic brain tumors; role of CTCF and homologues on
     gliomagenesis; microarray and SNP analysis of malignant brain tumors; clinical and outcomes research, including quality
     analysis; development of models of tumor formation, including mathematical modeling; identification of brain tumor and
     pituitary tumor stem cells; Phase O trials